Siebert U, Sroczynski G, Wasem J, Greiner W, Ravens-Sieberer U, Aidelsburger P, Kurth BM, Bullinger M, Graf von der Schulenburg JM, Wong JB, Rossol S (2005): Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany
Eur. J. Health Econ.: May 18; [Epub ahead of print].
mehr